Latest Pharmaceutical drug Stories
Dr. J G Moellendorf, DC, ND, LCP offers several tips regarding natural alternatives with fewer side-effects than common pain medications. Sturgeon Bay, WI (PRWEB) February 28, 2013 Many patients have consulted Sturgeon Bay, Wisconsin Chiropractor and Naturopath Dr. J G Moellendorf, DC, ND, LCP looking for non-drug and non-surgical solutions to relieve their chronic pain. Many had experienced adverse reactions and side-effects to pain medications and are looking for natural alternatives....
New iron supplement, with inner-cap multi-phase capsule delivery system, is newest addition to Avion's portfolio of Women's Health Care products ATLANTA, Feb. 26, 2013 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, announces the launch of FeRiva(TM) a new prescription iron supplement. FeRiva delivers two forms of iron utilizing a patented INNER CAP multi-compartment capsule technology. FeRiva contains 75 mg of elemental iron that includes Ferrochel®...
HONG KONG, Feb. 22, 2013 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular ("CCV") drug franchise in China's prescription market, today announced that Pinoxacin Hydrochloride, a Category 1.1 new drug developed by the Company's innovative drug research and development team, received Approval for Clinical Studies from the State Food...
LONDON, February 20, 2013 /PRNewswire/ -- Small-cap biotech stocks can provide big returns when they have a blockbuster drug in their portfolio. As in the case of Incyte Corporation (NASDAQ: INCY), the stock provided steep returns while the company's fortune is dependent on just one drug. The company announced strong Q4 results and provided robust outlook for the future performance. Arena Pharmaceuticals Inc. (NASDAQ: ARNA) also made impressive move on the strength of its...
FREDERICK, Md., Feb. 19, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, anti-inflammatory pain reliever devices is pleased to announce that its ActiPatch® Musculoskeletal Pain Relief Therapy product has received a nomination for the "Most Innovative New OTC Product Award" by the OTC Bulletin, the leading international trade publication for OTC developments worldwide. The OTC Bulletin is firmly established as the most...
SOLANA BEACH, Calif., Feb. 19, 2013 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (IMMY:NASDAQ) today announced the completion of a clinical study of Impracor(TM), a topical analgesic cream that delivers a therapeutic dose of the pain-relieving, anti-inflammatory drug ketoprofen. The study measured the amount of ketoprofen found in the bloodstream following topical application of two different doses of the anti-inflammatory cream under different conditions, including normal...
FREDERICK, Md., Feb. 14, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, anti-inflammatory pain reliever devices is pleased to announce that Gro-International, SA, Geneva, Switzerland market developers and brand management have added ActiPatch® Musculoskeletal Pain Therapy, Allay(TM) Menstrual Pain Therapy, and the Smart Insole(TM) Heel Pain Therapy products to their select group of retail products portfolio. The...
(H.R. 460) would end specialty tier cost sharing and provide relief for millions with arthritis ATLANTA, Feb. 7, 2013 /PRNewswire-USNewswire/ -- The Arthritis Foundation supports new bipartisan legislation introduced in the House of Representatives this week that will increase affordability of medications for more than seven million Americans, including 300,000 children, with rheumatoid arthritis (RA), and other inflammatory diseases. If passed, the Patients' Access to Treatment...
TriMix-gel Gets a New Home at US Compounding (PRWEB) February 05, 2013 TriMix Laboratories LLC today announced it has entered into an agreement with US Compounding, INC as the exclusive pharmacy for prescription fulfillment of TriMix-gel®. TriMix-gel has been prescribed by doctors as both a first line and secondary treatment for erectile dysfunction (ED). US Compounding is a licensed compounding pharmacy which makes TriMix-gel for each individual patient in response to a...
The recent Connecticut massacre and other mass killings have focused the current debate on gun control. In this recent interview, which follows up on Dr Healy's talk in New York City at a RxISK Forum On School Shootings 10 days ago, Healy explains why we need to have a serious discussion about the role that common US prescription drugs might have played. Toronto, Ontario (PRWEB) January 30, 2013 RxISK.org, the first free independent website for researching and reporting prescription...
